MEGF-0444A is safe as monotherapy or combined with bevacizumab/paclitaxel in solid tumors June 16, 2011
CytRx reports encouraging preliminary data from phase II ENABLE trial of bafetinib in B-CLL June 15, 2011
First-in-human data suggest safety of LY-2090314 in patients with advanced solid tumors June 15, 2011
RSS